CURE - Citizens United for Research in Epilepsy

As people around the world follow the evolving COVID-19 situation, we’re taking precautions to reduce risk to staff, donors, and volunteers, as well as provide information for the CURE community of patients, families, and caregivers. Do you have questions about COVID-19 and epilepsy? Ask the experts during a Facebook live stream tomorrow at 11:30AM CT!

New Emergency Meds to the RescueDuring this live stream, neurologist Dr. Jeffrey Loeb and neuroimmunologist Dr. Michael Carrithers from the University of Illinois at Chicago will field your questions on staying healthy and safe. Post your questions about COVID-19 and the implications for people with epilepsy in the comments of this post, and don’t forget to click the star button to get a reminder before we go live!

If you can’t join us live, you can view the archived stream on our Facebook page or on our website.

Please note, as the government institutes new guidance to help minimize the impact of COVID-19 on our community, the CURE staff has begun to work remotely. During this challenging time, our commitment to advancing research to cure epilepsy remains unwavering. While we are out of office, the team continues to be available via phone, email, or social media. Please do not hesitate to reach out to us.

May you and your loved ones remain healthy and safe.

Warmest,
5a0b940e-4dde-4325-ad3d-5f1255ffab18.png

Beth Lewin Dean, CEO


Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.

Donate
Facebook Twitter Instagram LinkedIn YouTube

View this email in your browser.

Our mailing address is:

Citizens United for Research in Epilepsy (CURE)
420 Wabash Ave, Ste 650
Chicago, IL 60611

Add us to your address book

Update your preferences or unsubscribe from this list
In the past you provided Citizens United for Research in Epilepsy your email address. Occasionally, you will receive updates from CURE about epilepsy research and news.